Clarify Health

MAY 19, 2020

There is also a looming, time-sensitive reality that biopharma companies face once their products hit the market: they need to recoup the costs of development as quickly as possible before drug patents expire and generics threaten sales. sales, medical science liaisons, etc.). Which physicians see these patients?

Biopharma 52

Biopharma Physicians Marketing Prescription 52

Medgadget

FEBRUARY 17, 2023

Thanks to kind support from Biomed Israel , the leading international Life Science and HealthTech conference in Israel (see more below), we met with Ronan Castro, the CEO of Human Xtensions at the company’s offices in Netanya, Israel. are still done in an open fashion.

Physicians 80

Physicians Engineering Side effects Leads 80

Medgadget

MARCH 22, 2023

Thanks to support from Biomed Israel , the leading international Life Science and HealthTech conference in Israel (see more below about the upcoming event), we had a chance to learn about Imagene’s technology from Dean Bitan, CEO and Co-Founder of the company. More info can be found at the Biomed Israel website.

Patients 79

Patients Medical science Leads Medical 79

Medgadget

MARCH 2, 2023

This leads to substantial damage to healthy tissues and too often results in poor outcomes. To make implantation of the Alpha DaRT sources easy and precise, the company developed dedicated applicators andadapted existing biopsy devices, that physicians are already acquainted with, to deliver the radioactive sources.

Manufacturing 83

Manufacturing Leads Patients Medicine 83